The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023

Lancet Reg Health West Pac. 2024 Jun 27:48:101125. doi: 10.1016/j.lanwpc.2024.101125. eCollection 2024 Jul.

EGASP-Vietnam WGS study group:
Le Huu Doanh, Pham Thi Lan, Pham Quynh Hoa, Pham Dieu Hoa, Pham Thi Minh Phuong, Trinh Minh Trang, Thai Thi Dieu Van, Pham Trieu Nam, Nguyen Thi Ha Vinh, Quach Thi Ha Giang, Vu Thanh Tung, Nguyen Doan Tuan, Hao Trong Nguyen, Thuy Thi Phan Nguyen, Thao Thi Phuong Vu, Phuong Thi Thanh Nguyen, Bao Hac Duong, Em Van Loi Doan, Dung Thi Thuy Nguyen, Khanh Tuan Le, Tan Minh Bui, Nguyen Nhat Pham, Trang Thi Kieu Nguyen, Trang Thi Thanh Phan, Anh Duy Quynh Dang, Nguyen Thi Thuy Van, Nguyen Trong Khoa, Monica Lahra, Robert McDonald, Kristen Kreisel, Ismael Maatouk, Teodora Wi, Daniel Golparian, Daniel Schröder, Susanne Jacobsson, Magnus Unemo

¹ National Hospital of Dermatology and Venereology, Hanoi, Viet Nam.
² Ho Chi Minh City Hospital of Dermatology and Venereology, Ho Chi Minh City, Viet Nam.
³ WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections (STIs), Örebro University, Örebro, Sweden.
⁴ WHO Country Office, Hanoi, Viet Nam.
⁵ Global HIV, Hepatitis and STI Programmes, WHO, Geneva, Switzerland.
⁶ Institute for Global Health, University College London (UCL), London, UK.

No abstract available

Grants and funding